抗组胺药在特应性皮炎治疗中使用情况的评估
研究利用2003-2012年美国门诊医疗调查数据,评估特应性皮炎就诊中镇静与非镇静抗组胺药的使用。结果显示抗组胺药在16%-44%的特应性皮炎就诊中被处方,皮肤科和儿科医生主要使用镇静类,而家庭/全科医生、内科医生及其他专科医生多数使用非镇静类。作者指出缺乏高级别证据支持非镇静抗组胺药减轻瘙痒或镇静类改善特应性皮炎症状。
要点
- 特应性皮炎年就诊量约99万次,抗组胺药处方比例为16%-44%。
- 皮肤科和儿科医生主要使用镇静类抗组胺药(58%-70%)。
- 家庭/全科、内科及其他专科医生多数使用非镇静类(55%-100%)。
核心结论
- 抗组胺药被广泛用于特应性皮炎治疗,但缺乏高级别证据支持非镇静类减轻瘙痒或镇静类改善特应性皮炎症状(或许对睡眠及特应性皮炎共病如过敏性鼻炎有益)。
研究设计与样本
- 研究基于2003-2012年美国国家门诊医疗调查(National Ambulatory Medical Care Survey)提供的医生就诊数据,识别特应性皮炎就诊中的镇静与非镇静抗组胺药使用。
主要发现
- 特应性皮炎年就诊量约99万次,各医生专科中抗组胺药处方比例范围为16%-44%。
- 皮肤科医生和儿科医生主要使用镇静类抗组胺药(58%-70%)。
- 家庭/全科医生、内科医生及其他专科医生多数处方非镇静类抗组胺药(55%-100%)。
关键数值与推荐
- 美国皮肤病学会不推荐抗组胺药常规用于特应性皮炎管理,但认可短期使用镇静类抗组胺药治疗继发于瘙痒的失眠的价值。
局限性
- 研究受限于特应性皮炎诊断和药物记录的准确性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Antihistamines are often used to treat pruritus associated with atopic dermatitis (AD) despite lack of evidence for their efficacy. The American Academy of Dermatology does not recommend the general use of antihistamines in the management of AD, although the value of short-term sedating antihistamine use for insomnia secondary to itch is recognized. OBJECTIVE: To assess the use of sedating and nonsedating antihistamines for AD in 2003-2012. METHODS: The National Ambulatory Medical Care Survey provided data on physician visits in 2003-2012. Sedating and nonsedating antihistamine use was identified at visits for AD. RESULTS: There were 990,000 annual visits for AD. Antihistamines were prescribed for AD in a significant proportion of visits across physician specialties (16%-44%). Dermatologists and pediatricians primarily used sedating antihistamines (58%-70%), whereas the majority of family/general practitioners, internists, and other specialists prescribed nonsedating antihistamines for AD (55%-100%) LIMITATIONS: We were limited by the accuracy of AD diagnosis and medication recording. CONCLUSIONS: Antihistamines are widely used for the treatment of AD. There is no high-level evidence to suggest that nonsedating antihistamines reduce itch in patients with AD or that sedating antihistamines provide benefit in controlling AD symptoms (except perhaps sleep and AD comorbidities, such as allergic rhinitis).
引用
- He A, Feldman SR, Fleischer AB, et al. An assessment of the use of antihistamines in the management of atopic dermatitis. J Am Acad Dermatol. 2018. PMID: 29317281. doi:10.1016/j.jaad.2017.12.077
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。